Table 2. Paired tissues from AA, CA, VIET breast cancer patients.
Sample | ID | Receptor status | Age | Ethnic group |
---|---|---|---|---|
Tumor | 1M | ER-/PR-/Her2- | 61 | AA |
Normal | 2N | |||
Tumor | 3M | ER-/PR-/Her2- | 43 | AA |
Normal | 4N | |||
Tumor | 5M | ER+/PR+/Her2+ | 58 | AA |
Normal | 6N | |||
Tumor | 7M | ER-/PR-/Her2- | 42 | AA |
Normal | 8N | |||
Tumor | 1M | ER-/PR-/Her2+ | 71 | CA |
Normal | 2N | |||
Tumor | 3M | ER+/PR-/Her2- | 62 | CA |
Normal | 4N | |||
Tumor | 5M | ER+/PR+/Her2- | 67 | CA |
Normal | 6N | |||
Tumor | 7M | ER-/PR-/ Her2- | 80 | CA |
Normal | 8N | |||
Tumor | 1M | ER-/PR-/Her2- | 45 | VIET |
Normal | 2N | |||
Tumor | 3M | ER-/PR-/Her2- | 47 | VIET |
Normal | 4N | |||
Tumor | 5M | ER-/PR-/Her2- | 46 | VIET |
Normal | 6N | |||
Tumor | 7M | ER-/PR-/Her2- | 35 | VIET |
Normal | 8N | |||
Cell Line | CRL2335 | ER-/PR-/Her2- | 60 | AA |
Cell Line | MDA-MB-468 | ER-/PR-/Her2- | 51 | AA |
Cell Line | Hs578T | ER-/PR-/Her2- | 74 | AA |
Cell Line | MDA-MB-231 | ER-/PR-/Her2- | 51 | CA |